Genewiz, John Theurer Cancer Center Team to Discover Ovarian Cancer Biomarkers | GenomeWeb

NEW YORK (GenomeWeb News) – Genewiz and the John Theurer Cancer Center at Hackensack University Medical Center today announced a collaboration for the discovery of ovarian cancer biomarkers.

The deal is aimed at identifying biomarkers from ovarian cancer samples that can be used to predict a patient's prognosis, as well as the outcomes from chemotherapy treatments. The cancer center will supply the samples for analysis at Genewiz's CLIA laboratory in South Plainfield, NJ.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.